Fullerton Brenna S, Hong Charles R, Jaksic Tom
Department of Surgery, Center for Advanced Intestinal Rehabilitation, Boston Children's Hospital and Harvard Medical School, 300 Longwood Avenue, Fegan 3, Boston, MA 02115.
Department of Surgery, Center for Advanced Intestinal Rehabilitation, Boston Children's Hospital and Harvard Medical School, 300 Longwood Avenue, Fegan 3, Boston, MA 02115.
Semin Pediatr Surg. 2017 Oct;26(5):328-335. doi: 10.1053/j.sempedsurg.2017.09.006. Epub 2017 Sep 9.
Management of pediatric intestinal failure has evolved in recent decades, with improved survival since the advent of specialized multidisciplinary intestinal failure centers. Though sepsis and intestinal failure associated liver disease still contribute to mortality, we now have growing data on the long-term outcomes for this population. While intestinal adaptation and parenteral nutrition weaning is most rapid during the first year on parenteral support, achievement of enteral autonomy is possible even after many years as energy and protein requirements decline dramatically with age. Intestinal transplant is an option for patients experiencing complications of long-term parenteral nutrition who are expected to have permanent intestinal failure, but outcomes are hindered by immunosuppression-related complications. Much of the available data comes from single center retrospective reports, with variable inclusion criteria, intestinal failure definitions, and follow-up durations; this limits the ability to analyze outcomes and identify best practices. As most children now survive long-term, the focus of management has shifted to the avoidance and management of comorbidities, support of normal growth and development, and optimization of quality of life for these medically and surgically complex patients.
近几十年来,小儿肠衰竭的管理有所发展,自专门的多学科肠衰竭中心出现以来,生存率有所提高。尽管脓毒症和肠衰竭相关肝病仍是死亡的原因,但我们现在有越来越多关于这一人群长期预后的数据。虽然在接受肠外支持的第一年,肠道适应和肠外营养撤减最为迅速,但随着能量和蛋白质需求随年龄大幅下降,即使多年后实现肠内自主也是有可能的。肠移植是预计患有永久性肠衰竭的长期肠外营养并发症患者的一种选择,但结果受到免疫抑制相关并发症的阻碍。现有数据大多来自单中心回顾性报告,纳入标准、肠衰竭定义和随访时间各不相同;这限制了分析结果和确定最佳实践的能力。由于现在大多数儿童都能长期存活,管理的重点已转向避免和管理合并症、支持正常生长发育以及优化这些医疗和手术复杂患者的生活质量。